Abstract

ObjectiveTo prospectively investigate the association between personal activity intelligence (PAI) — a novel metabolic metric which translates heart rate during physical activity into a simple weekly score — and mortality in relatively healthy participants in China whose levels and patterns of physical activity in addition to other lifestyle factors are different from those in high-income countries. Patients and MethodsFrom the population-based China Kadoorie Biobank study, 443,792 healthy adults were recruited between June 2004 and July 2008. Participant’s weekly PAI score was estimated and divided into four groups (PAI scores of 0, ≤50, 51–99, or ≥100). Using Cox proportional hazard analyses, we calculated adjusted hazard ratios (AHRs) for cardiovascular disease (CVD) and all-cause mortality related to PAI scores. ResultsDuring a median follow-up of 8.2 (interquartile range, 7.3 to 9.1) years, there were 21,901 deaths, including 9466 CVD deaths. Compared with the inactive group (0 PAI score), a baseline weekly PAI score greater than or equal to 100 was associated with a lower risk of CVD mortality, an AHR of 0.87 (95% CI, 0.81 to 0.94) in men, and an AHR of 0.84 (95% CI, 0.78 to 0.92) in women, after adjusting for multiple confounders. Participants with a weekly PAI score greater than or equal to 100 also had a lower risk of all-cause mortality (AHR, 0.93; 95% CI, 0.89 to 0.97 in men, and AHR, 0.93; 95%, 0.88 to 0.98 in women). Moreover, this subgroup gained 2.7 (95% CI, 2.4 to 3.0) years of life, compared with the inactive cohort. ConclusionAmong relatively healthy Chinese adults, the PAI metric was inversely associated with CVD and all-cause mortality, highlighting the generalizability of the score in different races, ethnicities, and socioeconomic strata.

Highlights

  • Compared with the inactive group (0 personal activity intelligence (PAI)), a weekly PAI score greater than or equal to 100 was associated with a 7% lower risk of all-cause mortality both in men and women (AHR, 0.93; 95% confidence interval (CI), 0.89 to 0.97) in men and adjusted hazard ratios (AHRs), 0.93; 95% CI, 0.88 to 0.98 in women) after adjusting for multiple confounders (Table 2)

  • Participants with a baseline weekly PAI score greater than or equal to 100 had a significantly lower risk of cardiovascular disease (CVD) mortality compared with the inactive group: 13% lower risk in men (AHR, 0.87; 95% CI, 0.81 to 0.94), and 16% lower risk in women (AHR, 0.84; 95% CI, 0.78 to 0.92) (Table 3)

  • For CVD mortality, the relative risk reductions associated with weekly PAI scores greater than or equal to 100 among smokers, overweight/obese, patients with hypertension, patients with diabetes, those who were between the ages of 60 and years, and those years of age or older were 12% (AHR, 0.88; 95% CI, 0.80 to 0.96), 18% (AHR, 0.82; 95% CI, 0.75 to 0.90), 22% (AHR, 0.78; 95% CI, 0.72 to 0.86), 31% (AHR, 0.69; 95% CI, 0.60 to 0.79), 14%

Read more

Summary

Methods

Study Participants The University ofOxford and the Chinese Academy of Medical Sciences jointly coordinate the China Kadoorie Biobank study, which is a nationwide prospective cohort study involving 10 diverse regions in China. The study design and methods have been previously described.[18,19] Briefly, participants were recruited from 10 (five urban and five rural) diverse areas in China, chosen from China’s nationally representative Disease Surveillance Points (DSP) system[20,21] to maximize geographic and socioeconomic diversity. Of the w1.8 million eligible adults in these regions who were invited to study clinics between June 2004 and July 2008, a total of 512,714 participants 30 to 79 years of age were eligible for inclusion. We excluded participants with a self-reported clinical diagnosis of ischemic heart disease and stroke (n1⁄423,129), cancer (n1⁄42385), or those with chronic obstructive

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.